Science Wiki

A virus is a submicroscopic, obligate intracellular infectious agent composed of a nucleic acid genome (either DNA or RNA, single- or double-stranded) encased within a protective proteinaceous coat termed a capsid, and in many families surrounded by a host-derived lipid envelope. Within systems biology, an extracellular viral particle (the virion) is metabolically inert: it cannot synthesize ATP, lacks ribosomes and tRNAs, and propagates via passive Brownian diffusion and receptor affinity. A virus transitions into an active replicative state (the virocell) only upon breaching a susceptible host cell, reprogramming host transcriptional, translational, and membrane-trafficking networks to assemble progeny virions.

Because a viral genome has limited coding capacity, virions construct their protective capsids from repeating identical protein subunits (protomers and capsomeres) that self-assemble along thermodynamic free-energy minima into three primary symmetries:

Helical, Icosahedral, and Complex Symmetry

• Helical Symmetry: Identical protomers bind Periodically along the helical sugar-phosphate backbone of the viral nucleic acid, forming either rigid rods (e.g., *Tobacco mosaic virus*, 18 × 300 nm) or flexible filamentous ribonucleoprotein tubules (e.g., Influenza, Ebola virus, and rabies virus).
• Icosahedral Symmetry: A closed 20-faced polyhedron with 12 vertices (5-fold rotational axes), 20 triangular faces (3-fold axes), and 30 edges (2-fold axes). Under Caspar-Klug quasi-equivalence theory, an icosahedral shell is composed of 60T protein subunits arranged into exactly 12 pentavalent pentamers and 10(T − 1) hexavalent hexamers, where the triangulation number T = h² + h·k + k² (for integers h, k ≥ 0; e.g., T = 1, 3, 4, 7, 13, 16).
• Complex Morphology: Virions that combine multiple symmetries or specialized macromolecular injection machines. Tailed bacteriophages (*Caudoviricetes*, such as phage T4) couple an icosahedral prolate head containing dsDNA to a helical contractile tail sheath and baseplate fibers that mechanically puncture bacterial peptidoglycan cell walls. Poxviruses (*Variola*, *Vaccinia*) assemble brick-shaped multi-layered cores flanked by lateral bodies.

Enveloped Virions vs. Non-Enveloped Capsids

• Viral Envelope: Many animal viruses—including *Flaviviridae*, *Coronaviridae*, *Orthomyxoviridae*, and *Retroviridae*—acquire an outer lipid bilayer during budding through the host plasma membrane, endoplasmic reticulum, or Golgi apparatus. Embedded within this envelope are viral glycoproteins (spikes) that mediate receptor attachment and pH- or receptor-triggered membrane fusion.
• Giant Viruses (*Nucleocytoviricota*): The discovery of *Mimivirus*, *Pandoravirus*, and *Tupanvirus* (capsid diameters of 400–1,500 nm and dsDNA genomes up to 2.5 Mb encoding >2,500 proteins, including aminoacyl-tRNA synthetases and translation factors) blurred the boundary between cellular microbes and the virosphere, highlighting extensive horizontal gene transfer.

Formulated by Nobel laureate David Baltimore in 1971, the Baltimore Classification System categorizes all viruses into seven operational classes according to their genomic nucleic acid chemistry and the molecular pathway used to transcribe positive-sense messenger RNA (+mRNA) readable by host ribosomes:

Intracellular viral propagation proceeds through six sequential kinetic stages:

1. Attachment, Entry, and Uncoating

1. Receptor-Mediated Attachment: Viral surface proteins bind specific host cell-surface receptors and co-receptors—such as HIV-1 gp120 binding CD4 and CCR5/CXCR4, SARS-CoV-2 Spike binding ACE2, or influenza hemagglutinin binding sialic acid—defining cellular and tissue tropism.
2. Penetration and Entry: Enveloped viruses fuse their lipid bilayer directly with the plasma membrane or enter via clathrin/caveolin-mediated endocytosis followed by acid-triggered conformational rearrangement of class I, II, or III fusion glycoproteins inside the maturing endosome (pH 5.0–6.0). Non-enveloped viruses translocate across membranes via pore formation or endosomal lysis.
3. Uncoating: Dissociation of the capsid shell releases the viral genome into the cytoplasm (most RNA viruses) or transports it through the nuclear pore complex into the cell nucleus (most DNA viruses, retroviruses, and influenza).

2. Gene Expression, Replication Factories, and Egress

1. Macromolecular Synthesis & Membrane Remodeling: Positive-strand RNA viruses remodel host ER, Golgi, or mitochondrial membranes into invaginated double-membrane vesicles (replication organelles) that shield double-stranded RNA replication intermediates from cytosolic innate immune sensors.
2. Self-Assembly and Maturation: Newly replicated genomes carrying packaging signals (ψ elements) nucleate capsid self-assembly, followed by proteolytic cleavage of polyproteins (e.g., by HIV-1 protease or flavivirus NS2B-NS3 protease) to yield infectious virions.
3. Release (Egress): Non-enveloped viruses typically release progeny via cell lysis or non-lytic exocytic vesicles, whereas enveloped viruses bud through host membranes via ESCRT pathway recruitment.

Lytic vs. Lysogenic Bacteriophage Cycles

Viruses that infect bacteria (bacteriophages) execute two distinct life strategies:

• Lytic Cycle (Virulent Phages): Phages such as T4 immediately arrest host gene expression, replicate phage DNA, assemble ratusan of progeny particles, and express holins and endolysins to rupture the peptidoglycan wall within 20–40 minutes.
• Lysogenic Cycle (Temperate Phages): Phages such as phage λ integrate their genome into the bacterial chromosome via site-specific integrase as a quiescent prophage (repressed by the cI repressor), replicating passively during binary fission. When host DNA damage triggers the bacterial SOS response, RecA stimulates auto-cleavage of the cI repressor, excising the prophage and inducing lytic replication. Lysogenic conversion also transfers virulence toxin genes—such as Shiga toxin in *E. coli* O157:H7, cholera toxin in *Vibrio cholerae*, and diphtheria toxin in *Corynebacterium diphtheriae*.

Prokaryotic CRISPR-Cas and Eukaryotic Interferon Defenses

• Prokaryotic Antiphage Systems: Bacteria deploy restriction-modification endonucleases (which cleave unmethylated foreign DNA at palindromic motifs) and CRISPR-Cas adaptive immunity, which captures phage protospacer fragments into the chromosomal CRISPR locus and uses crRNA-guided Cas nucleases to cleave invading viral nucleic acids.
• Eukaryotic Innate & Adaptive Immunity: Vertebrate cells detect viral pathogen-associated molecular patterns (PAMPs) via Pattern Recognition Receptors—including endosomal Toll-like receptors (TLR3, TLR7/8, TLR9), cytosolic RNA helicases (RIG-I and MDA5), and the cytosolic DNA sensor cGAS-STING. Activation of IRF3/IRF7 and NF-κB drives secretion of Type I interferons (IFN-α/β), which induce hundreds of Interferon-Stimulated Genes (ISGs) such as Protein Kinase R (PKR, which phosphorylates eIF2α to halt translation), OAS/RNase L (which cleaves viral RNA), and tetherin.

Polymerase Fidelity, Quasispecies, and Antigenic Shift

While large dsDNA viruses (Class I) and *Coronaviridae* (which uniquely encode the ExoN nsp14 3'→5' proofreading exonuclease) replicate with relatively high fidelity, most viral RNA-dependent RNA polymerases (RdRps) and reverse transcriptases lack 3'→5' proofreading activity. Consequently, RNA viruses exhibit mutation rates of 10⁻⁵ to 10⁻³ substitutions per nucleotide per replication cycle—roughly one mutation per 10 kb genome copy.

Replication therefore generates a viral quasispecies: a swarm of closely related mutant sequences coupled by selection around a master consensus sequence. This mutational cloud enables rapid immune escape from neutralizing antibodies (antigenic drift) and antiviral drugs, while simultaneously imposing an upper genome-length limit (Eigen's error threshold), beyond which hypermutation induces lethal error catastrophe (a mechanism exploited by nucleoside analogs like molnupiravir and ribavirin). Furthermore, segmented RNA viruses (e.g., Influenza A with 8 RNA segments) coinfecting the same host cell can swap entire genomic segments (reassortment / antigenic shift), generating pandemic strains.

Viral Oncogenesis and Cell-Cycle Subversion

Approximately 12% to 20% of human cancers worldwide are attributable to seven oncoviruses: Human Papillomavirus (HPV-16/18), Epstein-Barr Virus (EBV), Hepatitis B and C viruses (HBV, HCV), Human T-lymphotropic virus-1 (HTLV-1), Kaposi sarcoma-associated herpesvirus (KSHV/HHV-8), and Merkel cell polyomavirus (MCPyV).

Small DNA tumor viruses must force quiescent host cells into S-phase cell cycle progression to access host DNA polymerase and deoxynucleotide pools. High-risk HPV strains accomplish this via two cooperating oncoproteins:

• E6 Oncoprotein: Recruits the host E3 ubiquitin ligase E6AP to polyubiquitinate the p53 tumor suppressor protein, targeting p53 for rapid proteasomal degradation and abolishing apoptosis and G₁ arrest following DNA damage.
• E7 Oncoprotein: Binds the hypophosphorylated retinoblastoma protein (pRb) via an LxCxE motif, displacing E2F transcription factors and inducing uncontrolled entry into S-phase DNA synthesis.

Are viruses considered living organisms?

Biophysically, viruses occupy the boundary between chemistry and biology. Extracellular virions are non-living macromolecular complexes that lack ribosomes, cell membranes, and ATP-generating metabolism. However, once inside a host cell, the infected virocell actively transcribes genes, replicates a heritable nucleic acid genome, and evolves via Darwinian natural selection—leading modern evolutionary biologists to classify viruses as obligate intracellular genetic parasites of the biosphere.

Why do RNA viruses mutate so much faster than DNA viruses?

Most DNA viruses replicate using DNA polymerases equipped with a 3'→5' exonuclease proofreading domain that excises mispaired bases, yielding low error rates of 10⁻⁸ to 10⁻⁷ mutations per nucleotide. By contrast, viral RNA-dependent RNA polymerases (except in coronaviruses) lack proofreading domains, resulting in error rates of 10⁻⁵ to 10⁻⁴ mutations per base—nearly 1,000 to 10,000 times higher.

How does the Baltimore Classification System group viruses?

Rather than grouping viruses by host species or disease symptoms, the Baltimore system classifies all viruses into seven classes (I–VII) based on their genome chemistry (DNA vs. RNA, single- vs. double-stranded, positive- vs. negative-sense) and whether they use reverse transcriptase to produce positive-sense mRNA (+mRNA) capable of being translated by host ribosomes.